Novo Nordisk A/S | NOVOB - Sales Revenues

Stock Price
243.20
Daily Change
8.10 3.45%
Monthly
-4.44%
Yearly
-39.79%
Q2 Forecast
224.75

Novo Nordisk reported DKK79.14B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Bausch Health Companies USD 2.8B 120M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Merck USD 16.4B 880M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Novo Nordisk DKK 79.14B 4.16B Dec/2025
Novo Nordisk DKK 12.53B 560M Dec/2025
Pacira USD 196.87M 17.35M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025